Calendar Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Market Closed - Börse Stuttgart 11:32:31 14/06/2024 am IST 5-day change 1st Jan Change
197.2 EUR +0.18% Intraday chart for Charles River Laboratories International, Inc. -1.13% -7.24%

Chart calendar Charles River Laboratories International, Inc.

38a5d38b48.qcTaXuOzxXyx3m9_GaO96JkQK1mMPbNtDTFYuhdmPzc.woOgHI2K_C7nlg4ef9nI29gieyDkeOUqQ3cf21YRDl_-lYoG0NSvPf_vLg~a1e729164697f61d342699f40d708c82

Upcoming events on Charles River Laboratories International, Inc.

31/07/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
12/02/2025 Q4 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Charles River Laboratories International, Inc.

05/06/2024 07:30 pm Jefferies Global Healthcare Conference
04/06/2024 08:30 pm William Blair Growth Stock Conference
09/05/2024 06:00 pm Q1 2024 Earnings Call
09/05/2024 04:30 pm Q1 2024 Earnings Release
08/05/2024 05:30 pm Annual General Meeting
10/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:6181
10/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:5467
10/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:5315
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:4703
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:4413
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:4224
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:4191
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:4186
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:4182
09/04/2024 09:30 pm American Association for Cancer Research Meeting - Poster No:3975
09/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:2841
09/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:2840
09/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:2835
09/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:2714
09/04/2024 02:00 am American Association for Cancer Research Meeting - Poster No:2630

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2 621
2 614
0.28%
2 924
2 891
1.15%
3 540
3 522
0.52%
3 976
3 915
1.56%
4 129
4 107
0.54%

4 221

EBITDA
Million USD
Released
Forecast
Spread
604
597
1.28%
701
693
1.26%
879
878
0.22%
991
982
0.87%
1 013
1 017
-0.4%

1 063

EBIT
Million USD
Released
Forecast
Spread
497
489
1.64%
585
575
1.73%
742
738
0.51%
834
820
1.67%
839
842
-0.35%

870

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
304
284
7.16%
447
394
13.45%
481
449
7.01%
623
568
9.63%
581
513
13.41%

534

Net income
Million USD
Released
Forecast
Spread
252
240
4.84%
364
296
23%
391
358
9.2%
486
409
18.85%
475
387
22.66%

410

EPS
USD
Released
Forecast
Spread
5,07
4,85
4.57%
7,20
5,88
22.44%
7,60
6,99
8.67%
9,48
7,97
18.98%
9,22
7,49
23.07%

7,95

Announcement Date11/02/2017/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
914
909
0.58%
973
995
-2.22%
989
970
1.93%
1 100
1 035
6.26%
1 029
986
4.39%
1 060
1 054
0.59%
1 027
1 000
2.61%
1 013
991
2.24%
1 012
993
1.82%

1 022


1 071


1 113


1 095


1 105

EBITDA
Million USD
Released
Forecast
Spread
233
233
0.02%
250
247
1.36%
240
238
1.14%
267
260
2.72%
260
252
3.03%
260
258
0.62%
255
241
5.8%
239
242
-1.38%
233
222
4.94%

243


285


304


263


269

EBIT
Million USD
Released
Forecast
Spread
196
194
1.26%
212
208
1.97%
201
197
2.26%
225
213
5.33%
218
209
3.98%
216
213
1.41%
211
194
8.51%
194
196
-1%
187
178
5.43%

196


238


255


228


234

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
111
149
-25.64%
144
142
1.83%
123
128
-3.67%
245
155
57.85%
131
150
-12.47%
129
143
-10.32%
113
120
-6.11%
209
120
74.62%
99,0
96,3
2.82%

110


156


169


150


157

Net income
Million USD
Released
Forecast
Spread
93,0
109
-14.63%
109
110
-0.34%
96,5
98,4
-1.95%
187
109
71.19%
103
102
0.7%
97,0
105
-7.26%
87,4
88,9
-1.74%
187
92,4
102.53%
67,3
71,2
-5.45%

83,6


122


131


117


117

EPS
USD
Released
Forecast
Spread
1,81
2,07
-12.39%
2,13
2,13
-0.04%
1,88
1,84
2.12%
3,65
2,14
70.86%
2,01
1,99
0.87%
1,89
2,04
-7.23%
1,69
1,68
0.51%
3,62
1,78
103.94%
1,30
1,35
-3.7%

1,68


2,32


2,58


2,16


2,21

Announcement Date04/05/2203/08/2202/11/2222/02/2311/05/2309/08/2308/11/2314/02/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. RV6 Stock
  5. Calendar Charles River Laboratories International, Inc.